Revista chilena de obstetricia y ginecología (0717-7526)
¿SE JUSTIFICA LA OOFORECTOMÍA, COMO MEDIDA PROFILÁCTICA EN LA DISMINUCIÓN DEL RIESGO DE CÁNCER DE OVARIO Y DE MAMA, EN LAS PACIENTES PORTADORAS DE MUTACIONES EN LOS GENES BRCA1 O BRCA2?
This tool is under development and it is available in Beta Test version
This tool is under development and it was published with the objective to test the usage and performance. All the indicators are real and they are gradually being loaded. Slowness and out of service problems may occur in this version.